Sykehuset Innlandet Reinsvoll
Reinsvoll, 2840, Norway
NCT Number: NCT03048695
About 85% of patients with schizophrenia have cognitive impairments, executive functions being particularly affected. Executive dysfunction, and cognitive deficits in general, are important predictors of functional outcomes, including social problem solving, activities of daily living, life satisfaction, and the ability to return to work or school.The main objective of the current study is to examine the efficacy of group-based Goal Management Training (GMT) for patients with broad schizophrenia spectrum disorders or high risk individuals with executive deficits. The short term goals are to investigate whether GMT can improve participants' ability to organize and achieve goals in everyday life in addition to improving aspects of emotional health. A long-term goal would be to establish an evidence base for nonpharmacological interventions for patients with broad schizophrenia spectrum disorders or high risk for schizophrenia. Main research questions: (1) Does a RCT with GMT delivered to patients with broad schizophrenia spectrum disorders or high risk for schizophrenia result in improved executive functioning, measured by self-reported and/or objective measures of executive functions? (2) Does GMT result in improved goal attainment in everyday life, social- and real world functioning? (3) Does GMT have a positive impact on the patients' emotional health? (4) Are there specific characteristics in patients with broad schizophrenia spectrum disorders or high risk for schizophrenia that are associated with better treatment benefit from GMT?
Looking for future studies?
Notify Me16 year–67 year
All sexes
Interventional
Not applicable
Reinsvoll, 2840, Norway
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Metacognitive strategy training where the primary objective is to stop ongoing behavior to define goal hierarchies and monitor performance
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Assessing change
Sykehuset Innlandet HF
Other
Cognitive Remediation of Executive Dysfunction - Goal Management Training for Patients With Schizophrenia or High Risk for Schizophrenia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06539780
Mental Disorders, Neurocognitive Disorders
Amsterdam-Zuidoost, North Holland, Netherlands
View Trial DetailsNCT00004571
Mental Disorders, Normal Physiology
Bethesda, Maryland, United States
View Trial DetailsNCT05808244
Mental Disorders, Psychosis
Kowloon, Hong Kong
View Trial DetailsNCT01945333
Mental Disorders, Psychotic Disorders
Brooklyn, New York, United States
View Trial Details